Imvexxy FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved May 29, 2018)
Brand name: Imvexxy
Generic name: estradiol
Dosage form: Vaginal Inserts
Previous Name: TX-004HR
Company: TherapeuticsMD, Inc.
Treatment for: Dyspareunia
Imvexxy (estradiol) is a bio-identical 17β-estradiol vaginal insert for the treatment of dyspareunia (vaginal pain during sexual intercourse) due to menopause.
Development Timeline for Imvexxy
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.